Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

ACAT inhibitors claimed by Sanwa for hyperlipidemia/atherosclerosis

July 3, 1998

Oxandrolone treatment results in robust anabolic effect in HIV-infected patients

July 3, 1998

New oxytocin antagonist for both parenteral and oral administration developed at Merck & Co.

July 2, 1998

JT develops more potent JTT-501 derivatives

July 2, 1998

Kissei investigates compounds for preventing abortion, premature birth

July 2, 1998

AMBI reports results confirming chromium picolinate's role in fat loss

July 2, 1998

Orlistat proves effective and well tolerated in the treatment of obesity

July 1, 1998

Novel aldose reductase inhibitor SG-210 for diabetic complications

July 1, 1998

Statins provide health benefits in women with normal cholesterol

July 1, 1998

First launch for Bayer's miglitol

June 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...